Background: Previous studies have suggested that an elevated pre-treatment neutrophil-to-
lymphocyte ratio (NLR) is associated with worse outcomes in patients with a variety of …

Background An elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poor
survival in patients with cancer, including those who receive immunotherapies. The authors …

Background Previous studies have suggested that an elevated baseline neutrophil-to-
lymphocyte ratio (BLNLR) and elevated relative change of NLR (ΔNLR%) is associated with …

Introduction Recently, the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) has
been widely evaluated in many cancers. Here we assessed the prognostic value of …

Background: A number of studies have investigated the prognostic impact of the neutrophil-
to-lymphocyte ratio (NLR) in patients with melanoma but the results were controversial …

Several studies have reported that a high neutrophil-to-lymphocyte ratio (NLR) is associated
with poor clinical outcomes in several cancers, but this ratio has not been thoroughly studied …

Immunotherapy has revolutionized the treatment in metastatic melanoma, but alternative
biomarkers that are economical, simple and reliable still need to be clarified. In this study …

Neutrophil‐to‐lymphocyte ratios (NLR) and eosinophil counts are associated with improved
survival in melanoma patients treated with immune checkpoint inhibitors, but no study has …

Aim: To examine neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio
(PLR) in prognosticating immunotherapy efficacy. Methods: A retrospective study of 156 …

Background Previous studies have suggested that elevated neutrophil-to-lymphocyte ratio
(NLR) is prognostic for worse outcomes in patients with a variety of solid cancers, including …